Table 2.
COVID-19 vaccination and hair/scalp concerns and symptoms among cicatricial alopecia patients
| Patient experience with COVID-19 vaccination: | Survey responses who received vaccine (n = 312) |
|---|---|
| Experienced concern regarding potential effect of COVID-19 vaccination on | |
| Hair loss | 107 (34.3%) |
| Scalp symptoms | 110 (35.3%) |
| Cicatricial alopecia treatments | 81 (26.0%) |
| Changed alopecia medications due to COVID-19 vaccination | |
| Yes – changed a medication | 15 (4.8%) |
| Stopped or paused medication | 12 (80.0%) |
| Increased dose/frequency | 1 (6.7%) |
| Decreased dose/frequency | 1 (6.7%) |
| Started new medication | 1 (6.7%) |
| Reason for medication change: | |
| Recommendation from physician | 8 (53.3%) |
| Personal concern about medication effects on vaccine efficacy | 7 (46.7%) |
| Increased hair loss related to vaccine | |
| Yes | 25 (8.0%) |
| Mild | 14 (56.0%) |
| Moderate | 7 (28.0%) |
| Severe | 4 (16.0%) |
| Had changed a medication due to vaccine | 3 (12.0%) |
| Hair loss has since normalized | 16 (64.0%) |
| Increased scalp symptoms related to vaccine | |
| Yes | 48 (15.4%) |
| Mild | 26 (54.2%) |
| Moderate | 20 (41.7%) |
| Severe | 2 (4.2%) |
| Had changed a medication due to vaccine | 5 (10.4%) |
| Scalp symptoms have since normalized | 30 (62.5%) |